COMMUNIQUÉS West-GlobeNewswire

Predicine Submits First Module of PMA Application to FDA for PredicineCARE™ as a Companion Diagnostic Assay in Bladder Cancer
02/09/2025
HAYWARD, Calif., Sept. 02, 2025 (GLOBE NEWSWIRE) -- Predicine, Inc. , a leading molecular insights company, today announced the submission of the first module of its premarket approval (PMA) application to the U.S. Food [...]
Femasys Closes $8 Million in Financing to Accelerate Commercialization of Fertility and Birth Control Portfolios
02/09/2025
--Existing investors, including Femasys’ largest shareholders, reaffirm confidence in Femasys’ strategy for growth and impact in women’s health-- ATLANTA, Sept. 02, 2025 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ: FEMY), [...]
Windtree Therapeutics Stockholders Approve Key Proposals for Revenue and Profit Generation at the Special Stockholder Meeting
02/09/2025
The Special Stockholder Meeting on August 28, 2025 recorded the proxy voting approvals of all ten of the Windtree proposals by stockholders The stockholder approved proposals provide the foundation for Windtree revenue [...]
Propanc Biopharma Announces Plan to Acquire $100 Million of Ethereum
02/09/2025
Ethereum to Enhance Multi-Faceted Corporate Strategy of Cryptocurrency Exposure, Pharmaceutical Drug Development & Asset Acquisition MELBOURNE, Australia, Sept. 02, 2025 (GLOBE NEWSWIRE) -- Propanc Biopharma, Inc. ( [...]
Senti Bio to Present at the H.C. Wainwright 27th Annual Global Investment Conference
02/09/2025
Live webcast presentation with Co-Founder and CEO, Dr. Timothy Lu, on September 8th at 2:00 PM ET SOUTH SAN FRANCISCO, Calif., Sept. 02, 2025 (GLOBE NEWSWIRE) -- Senti Biosciences, Inc. (Nasdaq: SNTI) (“Senti Bio”), a [...]
Trinity Biotech Regains Compliance with Nasdaq Listing Requirements
02/09/2025
DUBLIN, Sept. 02, 2025 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq Global Select: TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions, including wearable [...]
Perfusion Life Approved as GSA Vendor, Enhancing Cardiac Perfusion Staffing for VA Hospitals
02/09/2025
Raleigh, North Carolina, Sept. 02, 2025 (GLOBE NEWSWIRE) -- Perfusion Life , a nationally recognized provider of joint-commission accredited perfusion staffing, has been approved as a vendor on the General Services [...]
Precipio Terminates Its ATM
02/09/2025
Management Decision Further Reinforces Commitment to Responsible Capital Management NEW HAVEN, Conn., Sept. 02, 2025 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO) , has [...]
Lighthouse Autism Center Affirms Commitment to Nebraska Families Following Medicaid Rate Cuts
02/09/2025
MISHAWAKA, Ind., Sept. 02, 2025 (GLOBE NEWSWIRE) -- Lighthouse Autism Center announced today it will continue to provide Applied Behavior Analysis (ABA) therapy to Nebraska families despite a recent 48% reduction in [...]
Military Veterans Join Virtue Recovery to Expand Community Outreach with Hope and Support
02/09/2025
LAS VEGAS, Sept. 02, 2025 (GLOBE NEWSWIRE) -- Virtue Recovery is proud to announce the expansion of its Business Development Team with the addition of two U.S. military veterans: Adam Khosroabadi, U.S. Marine Corps [...]
Dianabol (Dbol) Pills 2025: DBal Max Launch Dianabol Anabolic Legal Steroid Alternatives for Beginners Dosage Usage, Benefits & Results
02/09/2025
Dianabol (D-bol) Pills for Muscle Growth: Read Benefits, Dianabol Side Effects, Results, and advanced Alternatives Pills From D-Bal Max new york, Sept. 02, 2025 (GLOBE NEWSWIRE) -- August 31, 2025 | New York, (Dbal Max [...]
Trading by management and close relations of management
02/09/2025
Please read the announcement in PDF Attachment 2025_43_Trading_By_Management
FibroGen Completes Sale of FibroGen China to AstraZeneca for Approximately $220 Million
02/09/2025
Total consideration for the sale of FibroGen China to AstraZeneca is approximately $220 million, a $60 million increase from initial guidance Successfully repaid term loan to Morgan Stanley Tactical Value, further [...]
Seer Appoints Isaac Ro to its Board of Directors
02/09/2025
REDWOOD CITY, Calif., Sept. 02, 2025 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), the pioneer and trusted partner for deep, unbiased proteomic insights, today announced it has appointed Isaac Ro to serve on its Board [...]
Atea Pharmaceuticals to Present at the Morgan Stanley 23rd Annual Global Healthcare Conference
02/09/2025
BOSTON, Sept. 02, 2025 (GLOBE NEWSWIRE) -- Atea Pharmaceuticals, Inc. (Nasdaq: AVIR) (Atea or Company), a clinical-stage biopharmaceutical company engaged in the discovery and development of oral antiviral therapeutics [...]
Kamada to Participate in Upcoming September Investor Conferences
02/09/2025
REHOVOT, Israel, and HOBOKEN, N.J., Sept. 02, 2025 (GLOBE NEWSWIRE) -- Kamada Ltd. (NASDAQ: KMDA; TASE: KMDA.TA), a global biopharmaceutical company with a portfolio of marketed products indicated for rare and serious [...]
AlloFlo™ Uveo Achieves Key Milestones Ahead of Launch: 7 Peer-Reviewed Studies & 3,000 U.S. Cases
02/09/2025
Two new milestone publications confirm robust efficacy and safety profile of bio-Interventional uveoscleral outflow enhancement technology WHITE PLAINS, N.Y., Sept. 02, 2025 (GLOBE NEWSWIRE) -- Iantrek, Inc. today [...]
Neumora Therapeutics to Participate in Upcoming Conferences in September
02/09/2025
WATERTOWN, Mass., Sept. 02, 2025 (GLOBE NEWSWIRE) -- Neumora Therapeutics, Inc. (Nasdaq: NMRA), a clinical-stage biopharmaceutical company with a therapeutics pipeline consisting of seven programs that target novel [...]
Skye Completes 26-week Treatment Phase in Phase 2a CBeyond™ Study
02/09/2025
Skye also announces completion of enrollment of 26‑week extension study; 52‑week data planned, with post‑extension 13‑week follow‑up SAN DIEGO, Sept. 02, 2025 (GLOBE NEWSWIRE) -- Skye Bioscience, Inc. (Nasdaq: SKYE) (“ [...]

Pages